• 

  Q&A: Insights From a Long-Running Study of Alzheimer’s Risk
• 

  Some Alzheimer’s, Parkinson’s Therapies May Cause Brain Inflammation
• 

  This Drug Is Fighting Alzheimer’s in Aged Squirrel Monkeys—Up Next: Human Trials
• 

  ‘Some Hope Over No Hope:’ A Retired Doctor on Alzheimer’s Diagnosis and the Aduhelm Trial
• 

  Bio-Hermes Study Underway To Develop Cost-Effective Alzheimer’s Diagnostics
• 

  Can Nicotine Patches Snuff Out Mild Cognitive Impairment? Clinical Trial Underway
• 

  Lack of Clinical Trial Diversity Is Hurting Dementia Research
• 

  Meet Lilly’s Investigational Alzheimer’s Drug Donanemab: A Q&A With Dr. David Weidman
• 

  FDA Head Calls for Investigation Into Controversial Aduhelm Approval
• 

  ‘Cautiously Optimistic:’ Cancer Drug Sargramostim May Improve Memory in Alzheimer’s
• 

  A Retired Neurologist On His Experience With Aduhelm’s Side Effects
• 

  Trial and Lots of Error: Experts Say Alzheimer’s Clinical Trials Need a Rethink
• 

  What Is Aduhelm and How Does It Fight Alzheimer’s?
• 

  Experts Respond to Aduhelm Approval
• 

  Our Experience With Aduhelm: Inside the Clinical Trial

Previous678Next